Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.8011
-0.0137 (-1.68%)
At close: Oct 9, 2026, 4:00 PM EDT
0.819295
+0.0182 (2.27%)
After-hours: Oct 9, 2026, 7:52 PM EDT
Akebia Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $4 | Buy | Maintains | $4 | +399.31% | Sep 15, 2026 |
| Westpark Capital | Westpark Capital | Buy Initiates $4.5 | Buy | Initiates | $4.5 | +461.73% | Sep 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $4 | Buy | Maintains | $4 | +399.31% | Aug 17, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $1 | Hold | Downgrades | $1 | +24.83% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $6 | Buy | Reiterates | $6 | +648.97% | Aug 6, 2026 |